Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2026-01-20 @ 11:35 PM
Study NCT ID:
NCT03230292
Status:
COMPLETED
Last Update Posted:
2022-07-22
First Post:
2017-07-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis
Sponsor:
UCB Biopharma SRL
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-03
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03-06
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-24
First Submit QC Date:
None
Study First Post Date:
2017-07-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-03-03
Results First Submit QC Date:
None
Results First Post Date:
2022-03-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-03-06
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-07-15
Last Update Post Date:
2022-07-22
Last Update Post Date Type:
ACTUAL